[Hazards of anticoagulant therapy].
作者信息
HOLZKNECHT F
出版信息
Med Klin. 1959 Mar 13;54(11):483-6.
PMID:13643616
Abstract
摘要
相似文献
1
[Hazards of anticoagulant therapy].
Med Klin. 1959 Mar 13;54(11):483-6.
2
[Hazards of depression in Rauwolfia therapy].
Sven Lakartidn. 1956 Apr 20;53(16):1021-3.
3
Production of premature ventricular contractions by Rauwolfia.
J Am Med Assoc. 1955 Dec 3;159(14):1363-4. doi: 10.1001/jama.1955.02960310027012.
4
Edema and congestive failure related to administration of Rauwolfia serpentina.
J Am Med Assoc. 1955 Oct 1;159(5):439.
5
Depressive reactions in hypertensive patients; a comparison of those treated with Rauwolfia and those receiving no specific antihypertensive treatment.
Circulation. 1959 Mar;19(3):366-75. doi: 10.1161/01.cir.19.3.366.
6
Circulatory responses during anesthesia of patients on Rauwolfia therapy.
J Am Med Assoc. 1956 Jul 21;161(12):1143-4. doi: 10.1001/jama.1956.02970120025007.
7
[Psychiatric experiences with megaphen (largactil) and the Rauwolfia alkaloid serpasil with special reference to Parkinson's psychomotor syndrome].
Nervenarzt. 1955 Dec 20;26(12):507-10.
8
Depression and anxiety occurring during Rauwolfia therapy.
J Am Med Assoc. 1955 Oct 29;159(9):836-9. doi: 10.1001/jama.1955.02960260006002.
9
[Parkinson like manifestations produced by medicamentation].
Med Klin. 1955 Apr 15;50(15):634-5.
10
Hematemesis and melena complicating treatment with Rauwolfia alkaloids.
AMA Arch Intern Med. 1957 Feb;99(2):218-21. doi: 10.1001/archinte.1957.00260020054009.
Zotero 插件